A 32-year-old female patient presented complaining of increased flushing, perspiration and heat intolerance of 3 months' duration. Medical history included idiopathic thrombocytopenic purpura of 4 years' duration, which had been treated by splenectomy after failed immunosuppression with prednisone and azathioprine and was currently in remission. On examination, she was found to be clinically euthyroid without a goiter. She had also developed a diffuse erythematous popular rash on the face and back, with bullous lesions on the chest. Immunofluorescent antibody studies performed on a punch biopsy of skin were positive for several autoantibodies, leading to a diagnosis of subacute cutaneous lupus erythematosus. This diagnosis was further characterized by positive titers of nuclear and doublestranded DNA autoantibodies in the serum. Thyroid function testing on an Advia Centaur ® Immunoassay System (Siemens Medical Solutions Diagnostics) revealed an increased concentration of serum free thyroxine (FT 4 ) 2 , 90.1 pmol/L (6.97 ng/dL) (reference range 11.5-22.7 pmol/L), a nonsuppressed thyroidstimulating hormone (TSH) concentration of 1.8 mIU/L (1.8 μIU/mL) (reference range 0.35-5.5 mIU/L), and normal free triiodothyronine (FT 3 ) concentration of 4.2 pmol/L (0.33 ng/dL) (reference range 3.5-6.5 pmol/L). Repeat investigation 1 and 2 months later revealed a progressive increase in FT 4 to 125.3 pmol/L (9.7 ng/dL) and ≥155 pmol/L (≥12.0 ng/dL), respectively. TSH and FT 3 remained within reference intervals, as did total T 4 by RIA, at 155 nmol/L (12 μg/dL) (reference range 58-161 nmol/L). Furthermore, she tested positive for antithyroperoxidase antibodies at 110 IU/L (reference range <37 IU/L) and antithyroglobulin antibodies at 149 IU/L (reference range <98.1). An investigation of her disconcordant thyroid function tests was initiated.
CASE DESCRIPTION
A 32-year-old female patient presented complaining of increased flushing, perspiration and heat intolerance of 3 months' duration. Medical history included idiopathic thrombocytopenic purpura of 4 years' duration, which had been treated by splenectomy after failed immunosuppression with prednisone and azathioprine and was currently in remission. On examination, she was found to be clinically euthyroid without a goiter. She had also developed a diffuse erythematous popular rash on the face and back, with bullous lesions on the chest. Immunofluorescent antibody studies performed on a punch biopsy of skin were positive for several autoantibodies, leading to a diagnosis of subacute cutaneous lupus erythematosus. This diagnosis was further characterized by positive titers of nuclear and doublestranded DNA autoantibodies in the serum. Thyroid function testing on an Advia Centaur ® Immunoassay System (Siemens Medical Solutions Diagnostics) revealed an increased concentration of serum free thyroxine (FT 4 ) 2 , 90.1 pmol/L (6.97 ng/dL) (reference range 11.5-22.7 pmol/L), a nonsuppressed thyroidstimulating hormone (TSH) concentration of 1.8 mIU/L (1.8 μIU/mL) (reference range 0.35-5.5 mIU/L), and normal free triiodothyronine (FT 3 ) concentration of 4.2 pmol/L (0.33 ng/dL) (reference range 3.5-6.5 pmol/L). Repeat investigation 1 and 2 months later revealed a progressive increase in FT 4 to 125.3 pmol/L (9.7 ng/dL) and ≥155 pmol/L (≥12.0 ng/dL), respectively. TSH and FT 3 remained within reference intervals, as did total T 4 by RIA, at 155 nmol/L (12 μg/dL) (reference range 58-161 nmol/L). Furthermore, she tested positive for antithyroperoxidase antibodies at 110 IU/L (reference range <37 IU/L) and antithyroglobulin antibodies at 149 IU/L (reference range <98.1). An investigation of her disconcordant thyroid function tests was initiated.
A 15-year-old white girl presented with neck tenderness. On examination, a nodule was palpated in the right thyroid lobe. The neck was supple without abnormal lymphadenopathy. Eye findings related to Graves' orbitopathy were absent. Weight, height, and blood pressure were unremarkable, but the heart rate was high at 104-114 bpm. The patient had a history of attention deficit hyperactivity disorder (ADHD) and was taking atomoxetine and fluoxetine. There was no history of childhood neck irradiation or family history of thyroid cancer. Several maternal relatives have acquired thyroid dysfunction. (Table 1) . Analyses were conducted by chemiluminescent immunoassay on the Roche Elecsys 2010 platform. Free T 3 and free T 4 indices as calculated by the clinicians were 5.5 nmol/L (RI 1.3-2.4 nmol/L) and 292 nmol/L (RI 67-138 nmol/L), respectively, and, in the context of the patient's normal TSH concentration, suggested the possibility of inappropriate TSH secretion due to resistance to thyroid hormone or a TSH-secreting pituitary adenoma. Analyses for serum free T 4 measured by direct dialysis and RIA were conducted at Mayo Medical Laboratories and revealed a normal free T 4 of 16.8 pmol/L (RI 10.3-25.8 pmol/L) (1.3 ng/dL, RI 1-2 ng/dL). Although certain of the patient's features, including her tachycardia (1, 2), were consistent with the syndrome of inappropriate TSH secretion, this syndrome is extremely rare and the recommended standard of care is to repeat thyroid function tests after ≥1 week (2) to exclude the effects of nonthyroidal illness and to assess the possibility of laboratory artifact (3). Accordingly, the patient's scheduled surgery was postponed to accurately assess her thyroid function status.
